Annual D&A
$0.00
-$65.00 K-100.00%
31 December 2023
Summary:
Cyclerion Therapeutics annual depreciation & amortization is currently $0.00, with the most recent change of -$65.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$2.30 million (-100.00%). CYCN annual D&A is now -100.00% below its all-time high of $2.70 million, reached on 31 December 2019.CYCN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
N/A
30 September 2024
Summary:
Cyclerion Therapeutics quarterly depreciation & amortization is not available.CYCN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
N/A
30 September 2024
Summary:
Cyclerion Therapeutics TTM depreciation & amortization is not available.CYCN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | - | - |
| 3 y3 years | -100.0% | - | - |
| 5 y5 years | -100.0% | - | - |
CYCN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | |||||
| 5 y | 5 years | -100.0% | |||||
| alltime | all time | -100.0% |
Cyclerion Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(-100.0%) | - | - |
| Dec 2022 | $65.00 K(-86.2%) | $0.00(0.0%) | $65.00 K(-42.5%) |
| Sept 2022 | - | $0.00(-100.0%) | $113.00 K(-29.8%) |
| June 2022 | - | $17.00 K(-64.6%) | $161.00 K(-38.5%) |
| Mar 2022 | - | $48.00 K(0.0%) | $262.00 K(-44.5%) |
| Dec 2021 | $472.00 K(-79.5%) | $48.00 K(0.0%) | $472.00 K(-47.2%) |
| Sept 2021 | - | $48.00 K(-59.3%) | $894.00 K(-37.7%) |
| June 2021 | - | $118.00 K(-54.3%) | $1.43 M(-25.7%) |
| Mar 2021 | - | $258.00 K(-45.1%) | $1.93 M(-16.0%) |
| Dec 2020 | $2.30 M | $470.00 K(-20.1%) | $2.30 M(-7.4%) |
| Sept 2020 | - | $588.00 K(-4.1%) | $2.48 M(-4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $613.00 K(-2.1%) | $2.59 M(-7.6%) |
| Mar 2020 | - | $626.00 K(-4.1%) | $2.80 M(+3.7%) |
| Dec 2019 | $2.70 M(+76.7%) | $653.00 K(-6.3%) | $2.70 M(+7.4%) |
| Sept 2019 | - | $697.00 K(-15.5%) | $2.51 M(+16.6%) |
| June 2019 | - | $825.00 K(+57.1%) | $2.16 M(+27.0%) |
| Mar 2019 | - | $525.00 K(+12.7%) | $1.70 M(+11.1%) |
| Dec 2018 | $1.53 M(-12.4%) | $466.00 K(+37.1%) | $1.53 M(+43.9%) |
| Sept 2018 | - | $340.00 K(-7.1%) | $1.06 M(+47.1%) |
| June 2018 | - | $366.00 K(+2.8%) | $722.00 K(+102.8%) |
| Mar 2018 | - | $356.00 K | $356.00 K |
| Dec 2017 | $1.75 M | - | - |
FAQ
- What is Cyclerion Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual D&A year-on-year change?
- What is the all time high quarterly D&A for Cyclerion Therapeutics?
- What is the all time high TTM D&A for Cyclerion Therapeutics?
What is Cyclerion Therapeutics annual depreciation & amortization?
The current annual D&A of CYCN is $0.00
What is the all time high annual D&A for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual depreciation & amortization is $2.70 M
What is Cyclerion Therapeutics annual D&A year-on-year change?
Over the past year, CYCN annual depreciation & amortization has changed by -$65.00 K (-100.00%)
What is the all time high quarterly D&A for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly depreciation & amortization is $825.00 K
What is the all time high TTM D&A for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high TTM depreciation & amortization is $2.80 M